211 related articles for article (PubMed ID: 27803387)
1. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
[TBL] [Abstract][Full Text] [Related]
2. Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats.
Cohier C; Chevillard L; Risède P; Roussel O; Mégarbane B
Toxicol Lett; 2014 Jul; 228(2):75-84. PubMed ID: 24769261
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats.
Pirnay S; Megarbane B; Declèves X; Risède P; Borron SW; Bouchonnet S; Perrin B; Debray M; Milan N; Duarte T; Ricordel I; Baud FJ
Toxicol Sci; 2008 Nov; 106(1):64-73. PubMed ID: 18703559
[TBL] [Abstract][Full Text] [Related]
4. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
[TBL] [Abstract][Full Text] [Related]
5. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study.
Pirnay S; Bouchonnet S; Hervé F; Libong D; Milan N; D'Athis P; Baud F; Ricordel I
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):335-42. PubMed ID: 15203048
[TBL] [Abstract][Full Text] [Related]
7. Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice.
Alhaddad H; Cisternino S; Saubamea B; Schlatter J; Chiadmi F; Risède P; Smirnova M; Cochois-Guégan V; Tournier N; Baud FJ; Mégarbane B
Toxicology; 2013 Mar; 305():99-108. PubMed ID: 23376546
[TBL] [Abstract][Full Text] [Related]
8. Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone.
Bruce RD; Moody DE; Fang WB; Chodkowski D; Andrews L; Friedland GH
Am J Drug Alcohol Abuse; 2011 Jul; 37(4):224-8. PubMed ID: 21438849
[TBL] [Abstract][Full Text] [Related]
9. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.
Concheiro M; Jones HE; Johnson RE; Choo R; Huestis MA
Ther Drug Monit; 2011 Oct; 33(5):619-26. PubMed ID: 21860340
[TBL] [Abstract][Full Text] [Related]
10. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.
Alhaddad H; Cisternino S; Declèves X; Tournier N; Schlatter J; Chiadmi F; Risède P; Smirnova M; Besengez C; Scherrmann JM; Baud FJ; Mégarbane B
Crit Care Med; 2012 Dec; 40(12):3215-23. PubMed ID: 22975888
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats.
Vodovar D; Chevillard L; Caillé F; Risède P; Pottier G; Auvity S; Mégarbane B; Tournier N
Br J Anaesth; 2022 Mar; 128(3):584-595. PubMed ID: 34872716
[TBL] [Abstract][Full Text] [Related]
12. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Huang W; Moody DE; McCance-Katz EF
Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma.
Murphy CM; Huestis MA
J Mass Spectrom; 2005 Jan; 40(1):70-4. PubMed ID: 15637731
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
Concheiro M; Shakleya DM; Huestis MA
Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
[TBL] [Abstract][Full Text] [Related]
15. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
[TBL] [Abstract][Full Text] [Related]
16. Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.
Mariottini C; Gergov M; Ojanperä I
Drug Test Anal; 2021 Sep; 13(9):1658-1667. PubMed ID: 34047070
[TBL] [Abstract][Full Text] [Related]
17. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage.
Skopp G; Kniest A; Haisser J; Mann K; Hermann D
Int J Legal Med; 2011 Mar; 125(2):277-81. PubMed ID: 21301858
[TBL] [Abstract][Full Text] [Related]
19. Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction.
Ransohoff JR; Petrides AK; Piscitello GJ; Flood JG; Melanson SEF
Drug Alcohol Depend; 2019 Oct; 203():8-12. PubMed ID: 31394416
[TBL] [Abstract][Full Text] [Related]
20. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment.
Zhao W; Alshogran OY; Zhang H; Joshi A; Krans EE; Caritis S; Shaik IH; Venkataramanan R
J Mass Spectrom; 2024 Apr; 59(4):e5015. PubMed ID: 38501738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
